p21(CIP1) and p57(KIP2) control muscle differentiation at the myogenin step

Genes and Development

Volumn 13, Issue 2, 1999, Pages 213-224

  Zhang, Pumin ^a,b   Wong, Calvin ^a   Dou, Liu ^a   Finegold, Milton ^a   Harper, J Wade ^a   Elledge, Stephen J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Cdk inhibitors; Cell cycle arrest; Muscle cell differentation; Myogenin

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; MYOGENIN; PROTEIN P21; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; CELL CYCLE; GENE CONTROL; LUNG ALVEOLUS; MOUSE MUTANT; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; PRIORITY JOURNAL; SKELETAL MUSCLE;

EID: 0033556237     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.13.2.213     Document Type: Article

References (50)

1. Andres, V. and K. Walsh. 1996. Myogenin expression, cell-cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J. Cell Biol. 132: 657-666.
2. Bischoff, R. and H. Holtzer. 196. Mitosis and the processes of differentiation of myogenic cells in vitro. J. Cell Biol. 41: 188-200.
3. Bour, B.A., M.A. O'Brien, W.L. Lockwood, E.S. Goldstein, R. Bodmer, P.H. Taghert, S.M. Ahmayr, and H.T. Nguyen. 1995. Drosophila MEF2, a transcription factor that is essential for myogenesis. Genes & Dev. 9: 730-741.
4. Chen, P.L., D.J. Riley, Y. Chen, and W.H. Lee. 1996. Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. Genes & Dev. 10: 2794-2804.
5. Clarke, A.R., E.R. Maandag, M. van Roon, N.M. van der Lugt, M. van der Valk, M.L. Hooper, A. Berns, and H. te Riele. 1992. Requirement for a functional Rb-1 gene in murine development. Nature 359: 328-330.
6. Clegg, C.H., T.A. Linkhart, B.B. Olwin, and S.D. Hauschka. 1987. Growth factor control of skeletal muscle differentiation: Commitment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor. J. Cell Biol. 105: 949-956.
7. Cobrinik, D., M.H. Lee, G. Hannon, G. Mulligan, R.T. Bronson, N. Dyson, E. Harlow, D. Beach, R.A. Weinberg, and T. Jacks. 1996. Shared role of the pRB-related p130 and p107 proteins in limb development. Genes & Dev. 10: 1633-1644.
8. Crescenzi, M., S. Soddu, A. Sacchi, and F. Tato. 1995. Adenovirus infection induces reentry into the cell cycle of terminally differentiated skeletal muscle cells. Ann. N.Y. Acad. Sci. 752: 9-18.
9. Cserjesi, P., B. Lilly, C. Hinkley, M. Perry, and E.N. Olson. 1994. Homeodomain protein MHox and MADS protein myocyte enhancer-binding factor-2 converge on a common element in the muscle creatine kinase enhancer. J. Biol. Chem. 269: 16740-16745.
10. Deng, C., P. Zhang, J.W. Harper, S.J. Elledge, and P. Leder. 1995. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675-684.
11. Edmondson, D.G., G.E. Lyons, J.F. Martin, and E.N. Olson. 1994. Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis. Development 120: 1251-1263.
12. Endo, T. and B. Nadal-Ginard. 1989. SV40 large T antigen induces reentry of terminally differentiatied myotubes into cell cycle. In The cellular and molecular biology of muscle development (ed. L.H. Kedes and F.E. Stockdale), pp. 95-104. A.R. Liss, New York, NY.
13. Fero, M.L., M. Rivkin, M. Tasch, P. Porter, C.E. Carow, E. Firpo, K. Polyak, L.H. Tsai, V. Broudy, R.M. Perlmutter, K. Kaushansky, and J.M. Roberts. 1996. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 85: 733-744.
14. Fogel, M. and V. Defendi. 1967. Infection of muscle cultures from various species with oncogenic DNA viruses (SV40 and polyoma). Proc. Natl. Acad. Sci. 58: 967-973.
15. Graessmann, A., M. Graessmann, and M. Fogel. 1973. The relationship of polyoma virus-induced tumor (T) antigen to activation of DNA synthesis in rat myotubes. Dev. Biol. 35: 180-186.
16. Gu, W., J.W. Schneider, G. Condorelli, S. Kaushal, V. Mahdavi, and B. Nadal-Ginard. 1993. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72: 309-324.
17. Guo, K., J. Wang, V. Andres, R.C. Smith, and K. Walsh. 1995. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol. Cell. Biol. 15: 3823-3829.
18. Halevy, O., B.G. Novitch, D.B. Spicer, S.X. Skapek, J. Rhee, G.J. Hannon, D. Beach, and A.B. Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267: 1018-1021.
19. Harper, J.W. and S.J. Elledge. 1996. Cdk inhibitors in development and cancer. Curr. Opin. Genet. Dev. 6: 56-64.
20. Harper, J.W., G.R. Adami, N. Wei, K. Keyomarsi, and S.J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816.
21. Hasty, P., A. Bradley, J.H. Morris, D.G. Edmondson, J.M. Venuti, E.N. Olson, and W.H. Klein. 1993. Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature 364: 501-506.
22. Jacks, T., A. Fazeli, E.M. Schmitt, R.T. Bronson, M.A. Goodell, and R.A. Weinberg. 1992. Effects of an Rb mutation in the mouse. Nature 359: 295-300.
23. Kelly, A.M. 1983. Emergence of specialization of skeletal muscle. In Handbook of hhysiology (ed. L.D. Peachey), pp. 507-537. Williams & Williams, Baltimore, MD.
24. Kiyokawa, H., R.D. Kineman, K.O. Manova-Todorova, V.C. Soares, E.S. Hoffman, M. Ono, D. Khanam, A.C. Hayday, L.A. Frohman, and A. Koff. 1996. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 85: 721-732.
25. Lee, E.Y., C.Y. Chang, N. Hu, Y.C. Wang, C.C. Lai, K. Herrup, W.H. Lee, and A. Bradley. 1992. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359: 288-294.
26. Lilly, B., B. Zhao, G. Ranganayakulu, B.M. Paterson, R.A. Schulz, and E.N. Olson. 1995. Requirement of MADS domain transcription factor D-MEF2 for muscle formation in Drosophila. Science 267: 688-693.
27. Molkentin, J.D., B.L. Black, J.F. Martin, and E.N. Olson. 1995. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 83: 1125-1136.
28. Mulligan, G. and T. Jacks. 1998. The retinoblastoma gene family: Cousins with overlapping interests. Trends Genet. 14: 223-229.
29. Nabeshima, Y., K. Hanaoka, M. Hayasaka, E. Esumi, S. Li, and I. Nonaka. 1993. Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature 364: 532-535.
30. Nadal-Ginard, B. 1978. Commitment, fusion and biochemical differentiation of a myogenic cell line in the absence of DNA synthesis. Cell 15: 855-864.
31. Nakayama, K., N. Ishida, M. Shirane, A. Inomata, T. Inoue, N. Shishido, I. Horii, and D.Y. Loh. 1996. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85: 707-720.
32. Nead, M.A., L.A. Baglia, M.J. Antinore, J.W. Ludlow, and D.J. McCance. 1998. Rb binds c-Jun and activates transcription. EMBO J. 17: 2342-2352.
33. Novitch, B.G., G.J. Mulligan, T. Jacks, and A.B. Lassar. 1996. Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulate in S and G2 phases of the cell cycle. J. Cell Biol. 135: 441-456.
34. Olson, E.N. and W.H. Klein. 1994. bHLH factors in muscle development: Dead lines and commitments, what to leave in and what to leave out. Genes & Dev. 8: 1-8.
35. Parker, S.B., G. Eichele, P. Zhang, A. Rawls, A.T. Sands, A. Bradley, E.N. Olson, J.W. Harper, and S.J. Elledge. 1995. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science 267: 1024-1027.
36. Ramirez-Solis, R., H. Zheng, J. Whiting, R. Krumlauf, and A. Bradley. 1993. Hoxb-4 (Hox-2.6) mutant mice show homeotic transformation of a cervical vertebra and defects in the closure of the sternal rudiments. Cell 73: 279-294.
37. Rao, S.S., C. Chu, and D.S. Kohtz. 1994. Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators. Mol. Cell. Biol. 14: 5259-5267.
38. Schneider, J.W., W. Gu, L. Zhu, V. Mahdavi, and B. Nadal-Ginard. 1994. Reversal of terminal differentiation mediated by p107 in Rb-/-muscle cells. Science 264: 1467-1471.
39. Sellers, W.R., B.G. Novitch, S. Miyake, A. Heith, G.A. Otterson, F.J. Kaye, A.B. Lassar, and W.G. Kaelin, Jr. 1998. Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth. Genes & Dev. 12: 95-106.
40. Serrano, M., H. Lee, L. Chin, C. Cordon-Cardo, D. Beach, and R.A. DePinho. 1996. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85: 27-37.
41. Skapek, S.X., J. Rhee, D.B. Spicer, and A.B. Lassar. 1995. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 267: 1022-1024.
42. Skapek, S.X., J. Rhee, P.S. Kim, B.G. Novitch, and A.B. Lassar. 1996. Cyclin-mediated inhibition of muscle gene expression via a mechanism that is independent of pRB hyperphosphorylation. Mol. Cell. Biol. 16: 7043-7053.
43. Taylor, D.A., V.B. Kraus, J.J. Schwarz, E.N. Olson, and W.E. Kraus. 1993. E1A-mediated inhibition of myogenesis correlates with a direct physical interaction of E1A12S and basic helix-loop-helix proteins. Mol. Cell. Biol. 13: 4714-4727.
44. Tedesco, D., M. Caruso, L. Fischer-Fantuzzi, and C. Vesco. 1995. The inhibition of cultured myoblast differentiation by the simian virus 40 large T antigen occurs after myogenin expression and Rb up-regulation and is not exerted by transformation-competent cytoplasmic mutants. J. Virol. 69: 6947-6957.
45. Venuti, J.M., J.H. Morris, J.L. Vivian, E.N. Olson, and W.H. Klein. 1995. Myogenin is required for late but not early aspects of myogenesis during mouse development. J. Cell Biol. 128: 563-576.
46. Weinberg, R.A. 1995. The retinoblastoma protein and cell cycle control. Cell 81: 323-330.
47. Yaffe, D. and D. Gershon. 1967. The effect of polyoma virus on differentiating multinucleated muscle fibers. Isr. J. Med. Sci. 3: 329-330.
48. Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes & Dev. 11: 973-983.
49. Zacksenhaus, E., Z. Jiang, D. Chung, J.D. Marth, R.A. Phillips, and B.L. Gallie. 1996. pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis. Genes & Dev. 10: 3051-3064.
50. Zhang, P., N.J. Liegeois, C. Wong, M. Finegold, H. Hou, J.C. Thompson, A. Silverman, J.W. Harper, R.A. DePinho, and S.J. Elledge. 1997. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature 387: 151-158.